Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Thermography for breast cancer screening: Where is the evidence?

Jennifer Gunter, MD
Conditions
November 1, 2013
Share
Tweet
Share

Thermography uses heat sensitive infrared cameras to image the body and measure heat emission.

Solid tumors, even when they are tiny, have an increased blood flow and inflammation compared with non-cancerous tissue. Theoretically this could lead to a thermal gradient between a cancer and the surrounding non-cancerous tissues. Some animal studies indicate that thermography might detect heat differences between inflamed and non inflamed tissue and so it was postulated (initially back in the 70s) that thermography might be a potential screening tool for breast cancer. I remember going round the thermography barn (albeit for another diagnosis) in 1990 during a medical school elective in the U.K. The images were cool and there were lots of “oohs’ and “aahs” from patients, but I don’t remember it changing much.

But breast cancer screening without radiation! Sounds like a great idea! So, let’s look at the studies … except there are very few studies to look at. This is always a bit of a red flag, because If something is so truly amazing and such a game changer then typically everyone wants a piece of the action: doctors, researchers, universities, free-standing clinics, manufacturers, you name it, not just naturopathic or concierge clinics.

Trust me when I say that a new, radiation-free effective method of detecting breast cancer would be a game changer, so the lack of studies suggests the early data is just so poor that there is no point in going on (a bit like inventing a unicycle with a square wheel and then seeing everyone else whiz around on a round one).

For the record, there are two recent meta-analysis, both of which conclude there is no evidence to support the use of thermography either as a screening tool or a diagnostic tool for breast cancer. The highest quality prospective study that I found looked at thermography in women with breast symptoms and thermography was dismal. The positive predictive value, meaning the chance that a positive test meant cancer, was 25% for thermography versus 88% for ultrasound and 84% for mammography. Positive and negative predictive values were far better for ultrasound and mammography compared with thermography.

One positive study touted by proponents of thermography (Wishart et. al., EJSO 2010) still had weaker numbers than mammography and ultrasound, involved only 100 women (compared with the hundreds of thousands in mammography and ultrasound studies), and one of the authors has a major competing commercial interests as the co-founder of Infrared Sciences Corp (manufacturers of Sentinel BreastScan, a breast thermography machine) and left that company to develop software to interpret breast thermography.

There is absolutely no data to support thermography for breast cancer screening or as an aid for diagnosis. Health Canada has even issued a health advisory against breast thermography. It is illegal to advertise  or sell these machines in Canada to screen for breast cancer. The FDA has issued several warning letters  as promoting thermography for breast cancer screening is against the law in the United States.

At best thermography adds nothing to breast cancer screening or diagnosis and at worst it might lead women to seek biopsies because of false positive results or the even more worrisome false reassurance that they have been appropriately screened.

Why would a doctor recommend thermography? Either they haven’t read the literature on breast cancer screening or they are fleecing patients (financially and emotionally) into thinking they are getting “individualized,” “state of the art,” “natural” technology when in fact they are getting one of the oldest medicines in the book, snake oil.

Jennifer Gunter is an obstetrician-gynecologist and author of The Preemie Primer. She blogs at her self-titled site, Dr. Jen Gunter.

Prev

When it comes to psychiatry, primary care could use the help

November 1, 2013 Kevin 9
…
Next

Does restricting Vicodin make sense?

November 1, 2013 Kevin 16
…

Tagged as: Oncology/Hematology, Radiology

Post navigation

< Previous Post
When it comes to psychiatry, primary care could use the help
Next Post >
Does restricting Vicodin make sense?

ADVERTISEMENT

More by Jennifer Gunter, MD

  • The Ellen Show broadcasts potentially harmful information about ovarian cancer screening

    Jennifer Gunter, MD
  • Dear science: an appreciation

    Jennifer Gunter, MD
  • Are there too many female OB/GYNs?

    Jennifer Gunter, MD

More in Conditions

  • Pancreatic cancer racial disparities

    Earl Stewart, Jr., MD
  • Why burnout prevention starts with leadership

    Kim Downey, PT & Shari Morin-Degel, LPC
  • Are SGLT2 inhibitors safe for type 1 diabetes?

    Zehra Haider, MD
  • Re-examining the lipid hypothesis and statin use

    Larry Kaskel, MD
  • How the internship shortage harms Black students

    Jonathan Lassiter, PhD
  • Aligning psychiatric care and hospital costs

    Lionel Pereira, MD
  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • What AI can never replace in medicine

      Jessica Wu, MD | Physician
    • Why the MAHA plan is the wrong cure

      Emily Doucette, MPH and Wayne Altman, MD | Policy
    • Why burnout prevention starts with leadership

      Kim Downey, PT & Shari Morin-Degel, LPC | Conditions
    • Are SGLT2 inhibitors safe for type 1 diabetes?

      Zehra Haider, MD | Conditions
    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • A doctor’s letter from a federal prison

      L. Joseph Parker, MD | Physician
    • The dangerous racial bias in dermatology AI

      Alex Siauw | Tech
    • A surgeon’s view on RVUs and moral injury

      Rene Loyola, MD | Physician
    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • A sibling’s guide to surviving medical school

      Chuka Onuh and Ogechukwu Onuh, MD | Education
  • Past 6 Months

    • Rethinking the JUPITER trial and statin safety

      Larry Kaskel, MD | Conditions
    • How one physician redesigned her practice to find joy in primary care again [PODCAST]

      The Podcast by KevinMD | Podcast
    • I passed my medical boards at 63. And no, I was not having a midlife crisis.

      Rajeev Khanna, MD | Physician
    • When language barriers become a medical emergency

      Monzur Morshed, MD and Kaysan Morshed | Physician
    • The measure of a doctor, the misery of a patient

      Anonymous | Physician
    • A doctor’s struggle with burnout and boundaries

      Humeira Badsha, MD | Physician
  • Recent Posts

    • Pancreatic cancer racial disparities

      Earl Stewart, Jr., MD | Conditions
    • What AI can never replace in medicine

      Jessica Wu, MD | Physician
    • Why the MAHA plan is the wrong cure

      Emily Doucette, MPH and Wayne Altman, MD | Policy
    • Why burnout prevention starts with leadership

      Kim Downey, PT & Shari Morin-Degel, LPC | Conditions
    • Are SGLT2 inhibitors safe for type 1 diabetes?

      Zehra Haider, MD | Conditions
    • ChatGPT in medicine: risks, benefits, and safer documentation strategies [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Thermography for breast cancer screening: Where is the evidence?
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...